Short-term effects of recombinant human insulin-like growth factor I on metabolic control of patients with type II diabetes mellitus

Journal of Clinical Endocrinology and Metabolism

Volumn 77, Issue 6, 1993, Pages 1563-1568

  Schalch, Don S ^a   Turman, Nancy J ^a   Marcsisin, Victoria S ^b   Heffernan, Maika ^b   Guler, Hans Peter ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

RECOMBINANT HUMAN INSULIN; SOMATOMEDIN C;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; KIDNEY FUNCTION; LIPID BLOOD LEVEL; MALE; METABOLIC REGULATION; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS SECRETION; PRIORITY JOURNAL;

AGED; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; FEMALE; HUMAN; HYPOTENSION, ORTHOSTATIC; INSULIN; INSULIN-LIKE GROWTH FACTOR I; KIDNEY; MALE; MIDDLE AGE; RECOMBINANT PROTEINS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027141307     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem.77.6.8263142     Document Type: Article

References (32)

1. Jacob R, Barrett E, Plewe G, Fagin KD, Sherwin RS. 1989 Acute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat. J Clin Invest. 83:1717-1723.
2. Moxley III RT, Arner P, Moss A, et al. 1990 Acute effects of insulin-like growth factor I and insulin on glucose metabolism in vivo. Am J Physiol. 259:E561-E567.
3. Giacca A, Gupta R, Efendic S, et al. 1990 Differential effects of IGF-I and insulin on glucoregulation and fat metabolism in depan-creatized dogs. Diabetes. 39:340-347.
4. Rossetti L, Frontoni S, DiMarchi R, DeFronzo RA, Giaccari A. 1991 Metabolic effects of IGF-I in diabetic rats. Diabetes. 40:444-448.
5. Jacob RJ, Sherwin RS, Bowen L, et al. 1992 Metabolic effects of IGF-I and insulin in spontaneously diabetic BB/w Rats. Am J Physiol. 260:E262-E268.
6. Van Schravendijk CFH, Heylen L, Van den Brande JL, Pipeleers DG. 1990 Direct effect of insulin and insulin-like growth factor-I on the secretory activity of rat pancreatic beta cells. Diabetologia. 33:649-653.
7. Guler HP, Zapf J, Froesch ER. 1987 Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. N Engl J Med. 317:137-140.
8. Takano K, Hizuka N, Asakawa K, Sukegawa I, Shizume K, Demura H. 1990 Effects of subcutaneous administration of recombinant human insulin-like growth factor I (IGF-I) on normal human subjects. Endocrinol Jpn. 37:309-317.
9. Guler HP, Schmid C, Zapf J, Froesch ER. 1989 Effects of recombinant human insulin-like growth factor I on insulin secretion and renal function in normal human subjects. Proc Natl Acad Sri USA. 86:2868-2872.
10. Zenobi PD, Graf S, Ursprung H, Froesch ER. 1992 Effects of insulin-like growth factor-I on glucose tolerance, insulin levels, and insulin secretion in healthy man. J Clin Invest. 89:1908-1913.
11. Zenobi PD, Jaeggi-Groisman SE, Riesen WF, Rader ME, Froesch ER. 1992 Insulin-like growth factor-I improves glucose and lipid metabolism in type 2 diabetes mellitus. J Clin Invest. 90:2234-2241.
12. Quin JD, Fisher BM, Paterson KR, Inone A, Beastall GH, Mac-Cuish AC. 1990 Acute response to recombinant insulin-like growth factor I in a patient with Mendenhall's syndrome. N Engl J Med. 323:1425-1426.
13. Schoenle EJ, Zenobi PD, Torresani T, Werder EA, Zachmann M, Froesch ER. 1991 Recombinant human insulin-like growth factor I (rhIGF-I) reduces hyperglycaemia in patients with extreme insulin resistance. Diabetologia. 34:675-679.
14. Kuzuya H, Marsuura N, Sakamoto M, et al. 1993 Trial of insulinlike growth factor I therapy for patients with extreme insulin resistance syndromes. Diabetes. 42:696-705.
15. Reaven GM. 1988 Role of insulin resistance in human disease. Diabetes. 37:1595-1607.
16. Froesch ER, Zapf J. 1985 Insulin-like growth factors and insulin: comparative aspects. Diabetologia. 28:485-493.
17. Poggi C, LeMarchand-Brustel Y, Zapf J, Froesch ER, Freychet P. 1979 Effects and binding of insulin-like growth factor-I in the isolated soleus muscle of lean and obese mice: comparison with insulin. Endocrinology. 105:723-730.
18. Schalch DS, Turman NJ, Marcsisin V, Guler H-P. 1991 Shortterm metabolic effects of recombinant human insulin-like growth factor I (rhIGF-I) in type II diabetes mellitus. In: Spencer EM, ed. Modem concepts of insulin-like growth factors. New York: Elsevier; 705-713.
19. Rossetti L, Smith D, Shulman GI, Papachristou D, DeFronzo RA. 1987 Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J Clin Invest. 79:1510-1515.
20. Steiner G, Morita S, Vranic M. 1980 Resistance to insulin but not to glucagon in lean human hypertriglyceridemics. Diabetes. 29:899-905.
21. Hirschberg R, Kopple JD, Blantz RC, Tucker BJ. 1991 Effects of recombinant human insulin-like growth factor I on glomerular dynamics in the rat. J Clin Invest. 87:1200-1206.
22. Hirschberg R, Brunori G, Kopple JD, Guler HP. 1993 Effects of insulin-like growth factor I on renal function in normal men. Kidney Int. 43:387-397.
23. Zatz R, Meyer TW, Rennke HG, Brenner BM. 1985 Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci USA. 82:5963-5967.
24. Wiseman MJ, Bognetti E, Dodds R, Keen H, Viberti GC. 1987 Changes in renal function in response to protein restricted diet in type I (insulin dependent) diabetic patients. Diabetologia. 30:154-159.
25. Biglieri EG, Watlington CO, Forsham PH. 1961 Sodium retention with human growth hormone and its subfractions. J Clin Endocrinol Metab. 21:361-370.
26. Ho KY, Weissberger AJ. 1990 The antinatriuretic action of biosynthetic human growth hormone in man involves activation of the renin-angiotensin system. Metabolism. 39:133-137.
27. DeFronzo RA, Goldberg M, Agus Z. 1965 The effects of glucose and insulin on renal electrolyte transport. J Clin Invest. 58:83-90.
28. DeFronzo RA, Cooke CR, Andres R, Faloona GR, Davis PJ. 1975 The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest. 55:845-855.
29. McAloon-Dyke M, Sclater A, Fukagawa NK, et al. 1990 Insulinlike growth factor I has positive chronotropic effects. Clin Res. 38:413A.
30. Caro JF. 1991 Insulin resistance in obese and nonobese man. J Clin Endocrinol Metab. 73:691-695.
31. Ferrannini E, Haffner SM, Mitchell BD, Stern MP. 1991 Hyper-insulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia. 34:416-422.
32. Huse DM, Oster G, Killen AR, Lacey MJ, Colditz GA. 1989 The economic costs of non-insulin-dependent diabetes mellitus. JAMA. 262:2708-2713.